VIR Stock Summary and Trading Ideas (Vir Biotechnology | NASDAQ:VIR)

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

What symbol and exchange does Vir Biotechnology shares trade?

Vir Biotechnology trades on the NASDAQ stock market under the symbol VIR.

What is Vir Biotechnology stock price doing today?

As of September 8, 2026, VIR stock price declined to $11.18 with 1,554,672 million shares trading.

What is Vir Biotechnology's Beta?

VIR has a beta of 0.96, meaning it tends to be less sensitive to market movements. VIR has a correlation of 0.05 to the broad based SPY ETF.

How much is Vir Biotechnology worth?

VIR has a market cap of $1.80 billion. This is considered a Small Cap stock.

How much money does Vir Biotechnology make?

Last quarter Vir Biotechnology reported $239 million in Revenue and $.47 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.41.

What is the highest and lowest price Vir Biotechnology traded in the last 3 year period?

In the last 3 years, VIR traded as high as $14.45 and as low as $4.16.

What are the top ETFs holding Vir Biotechnology?

The top ETF exchange traded funds that VIR belongs to (by Net Assets): XBI, VTI, VB, VBK, SPSM.

Is Vir Biotechnology (VIR) a good investment?

VIR has outperformed the market in the last year with a price return of +115.4% while the SPY ETF gained +19.2%. VIR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +32.3% and +4.4%, respectively, while the SPY returned +3.9% and 0.0%, respectively.

What are the support and resistance levels for Vir Biotechnology (VIR)?

VIR support price is $10.96 and resistance is $11.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VIR shares will trade within this expected range on the day.